Skip to main content
Tulane Home Tulane Home

Completed Research

 

Clinical Trials

2019-2020

STUDY TITLE: A Phase 4 Randomized, Active-Comparator Controlled Clinical Trial to Study the Safety of Sugammadex (MK-8616) for the Reversal of Neuromuscular Blockade Induced by Either Rocuronium Bromide or Vecuronium Bromide in American Society of Anesthesiologists (ASA) Class 3 or 4 Subjects

SPONSOR:  Merck/MSD